Advancing Regulatory Science > Sept. 24-25, 2014 Public Workshop: Next Generation Sequencing Standards

Advancing Regulatory Science > Sept. 24-25, 2014 Public Workshop: Next Generation Sequencing Standards

Select Events

Familial Hypercholesterolemia Awareness Day is September 24th, 2014- the FH Foundation will raise awareness of familial hypercholesterolemia worldwide

FDA Public Workshop: Next Generation Sequencing Standards
Bethesda, Sept 24-25, 2014.

NIST Big Data Public Working Group
Washington, DC. Oct 27-30, 2014.

View other upcoming events

Sept. 24-25, 2014 Public Workshop: Next Generation Sequencing Standards

---

---

Workshop description:  

This public workshop on next-generation sequencing (NGS) technology, data formats standardization and promotion of interoperability protocols aims to facilitate establishing protocols for ensuring the safety and quality of next-generation sequencing (NGS)-related-information without sacrificing scientific merit or interfering with innovative processes.  This will be achieved by engaging NGS stakeholders in a forum to discuss the current use of NGS technology and the development of standards for related information.

In addition, it will highlight FDA-proposed guidelines for addressing NGS data storage, archival and quality control steps needed for computational biology protocols related to FDA relevant regulatory science.   

When:

 

September 24-25, 2014
8:30 a.m. to 5:00 p.m.

 

Where:

 

The National Institute of Health Campus
9000 Rockville Pike , Bldg. 35 Rm. 610
Bethesda, MD 20892

 

Logistics and Arrival Details Here

 

Register Here 

  

Please note: We have reached full capacity for in-person attendance.  However, you may register to attend remotely. To do this, please select “remote attendance list." More information about remote access will be available in the coming weeks.

 

Workshop organizer: FDA Genomic Working Group

 

FDA's Genomic Working Group consists of experts in high throughput sequencing technology application and bioinformatics relevance.  The group's goal is to

develop the IT infrastructure, material and data standards, and analytic approaches that are required to support use and application of this exciting new

technology to solve scientific questions and support regulatory decision-making.

 

It also aims to ensure that the resources and expertise required are identified, implemented, and developed in a coordinated fashion, both internally at FDA, and where feasible, with other government agencies.

 

Agenda

 

This draft agenda will be replaced by a final agenda to be posted shortly.

 

Contact:

 

khaled.bouri@fda.hhs.gov